JCU - January 2022 - 4

UK's #1 choice GAG therapy1
Continuity of treatment at home or in the community*
Helping you and your patients adapt
Sodium Hyaluronate | Sodium Chondroitin Sulphate | Calcium Chloride
clinically
proven2,3
unique
formulation
patent
protected
Catheter-free instillation via our patented iAluadapter®
There's no comparison
For guidance on how to continue GAG therapy in the community
Click here
1. UK IMS data (accessed Dec 2019) 2. Damiano R, et al. Prevention of recurrent urinary tract infections by intravesical administration of hyaluronic Acid and chondroitin sulphate: a placebo-controlled
randomised trial. Eur Urol. 2011 Apr; 59(4):645-51. Epub 2011 Jan 18. 3. De Vita D, Long-term efficacy of intravesical instillation of hyaluronic acid/chondroitin sulfate in recurrent bacterial cystitis: 36
months' follow-up. Clin.and Exp. Obstet. & Gynecol. - CEOG XLV n.2,2018 *iAluRil should only be administered at home after being trained by an appropriate healthcare professional
iAluRil® (sodium hyaluronate, sodium chondroitin sulphate and calcium chloride) 50ml Pre-filled syringe with Luer-Lock Adaptor and Ialuadapter® Prescribing Information
Presentation: 50ml sterile solution of sodium hyaluronate (1.6% w/v - 800mg/50ml), sodium
chondroitin sulphate (2% w/v - 1g/50ml) and calcium chloride (0.87% - 440mg/50ml) with a Luer-Lock
adaptor and Ialuadapter®. Indications: Temporary re-establishment of glycosaminoglycans (GAGs)
in the vesical urothelium in cases in which GAG loss can cause frequent and recurring problems
(i.e. cystitis of varying etiology, chronic inflammation). Method of use: For intravesical instillation.
Use with catheter: After patient urinates spontaneously, remove residual urine via catheter. Attach
Luer-Lock adaptor to top of prefilled syringe and apply onto sterile catheter previously in place in
bladder. Instil solution into bladder via catheter. Remove catheter and syringe and discard. Use with
IAluadapter®: After patient urinates spontaneously, fasten IAluadapter® to top of prefilled syringe.
Instil solution into bladder through IAluadapter®. Remove IAluadapter® and syringe and discard.
For both methods of administration retain iAluRil in bladder for minimum of 30 minutes. Dosage:
One bladder instillation of iAluRil 50ml per week for first month, one instillation every two weeks for
second month and one instillation a month in following months until stable remission of symptoms
or according to medical prescription. Contraindications: Patients with known hypersensitivity to
any component. Legal category: Class III Medical Device. Cost: £88 for 50ml prefilled syringe with
Luer-Lock adaptor and IAluadapter®. CE number: CE 0373 for prefilled syringe, CE 0482 for LuerLock
adaptor and CE 1011 for iAluadapter®. Manufacturer: IBSA FARMACEUTICI ITALIA SRL, Via
Martiri di Cefalonia, 2 26900 Lodi (LO), Italy. Distributor: Aspire Pharma Ltd, Unit 4, Rotherbrook
Court, Bedford Road, Petersfield, Hampshire GU32 3QG, UK. Date reviewed: October 2020. Version
number: 1010244269 v 3.0
Adverse events should be reported. Reporting forms and information can be
found at www.mhra.gov.uk/yellowcard
Adverse events should also be reported to Aspire Pharma Ltd. (Tel: 01730 231148)
Sodium Hyaluronate | Sodium Chondroitin Sulphate | Calcium Chloride
10102441074 v 1.0 December 2020
www.aspirepharma.co.uk
https://ialuril.co.uk/about-ialuril-hcp/?utm_source=sept&utm_medium=email&utm_campaign=jcu http://www.aspirepharma.co.uk

JCU - January 2022

Table of Contents for the Digital Edition of JCU - January 2022

Contents
JCU - January 2022 - Cover1
JCU - January 2022 - Contents
JCU - January 2022 - 2
JCU - January 2022 - 3
JCU - January 2022 - 4
JCU - January 2022 - 5
JCU - January 2022 - 6
JCU - January 2022 - 7
JCU - January 2022 - 8
JCU - January 2022 - 9
JCU - January 2022 - 10
JCU - January 2022 - 11
JCU - January 2022 - 12
JCU - January 2022 - 13
JCU - January 2022 - 14
JCU - January 2022 - 15
JCU - January 2022 - 16
JCU - January 2022 - 17
JCU - January 2022 - 18
JCU - January 2022 - 19
JCU - January 2022 - 20
JCU - January 2022 - 21
JCU - January 2022 - 22
JCU - January 2022 - 23
JCU - January 2022 - 24
JCU - January 2022 - 25
JCU - January 2022 - 26
JCU - January 2022 - 27
JCU - January 2022 - 28
JCU - January 2022 - 29
JCU - January 2022 - 30
JCU - January 2022 - 31
JCU - January 2022 - 32
JCU - January 2022 - 33
JCU - January 2022 - 34
JCU - January 2022 - 35
JCU - January 2022 - 36
JCU - January 2022 - 37
JCU - January 2022 - 38
JCU - January 2022 - 39
JCU - January 2022 - 40
JCU - January 2022 - 41
JCU - January 2022 - 42
JCU - January 2022 - 43
JCU - January 2022 - 44
JCU - January 2022 - 45
JCU - January 2022 - 46
JCU - January 2022 - 47
JCU - January 2022 - 48
JCU - January 2022 - 49
JCU - January 2022 - 50
JCU - January 2022 - 51
JCU - January 2022 - 52
JCU - January 2022 - 53
JCU - January 2022 - 54
JCU - January 2022 - 55
JCU - January 2022 - 56
JCU - January 2022 - 57
JCU - January 2022 - 58
JCU - January 2022 - 59
JCU - January 2022 - 60
JCU - January 2022 - 61
JCU - January 2022 - 62
JCU - January 2022 - 63
JCU - January 2022 - 64
JCU - January 2022 - 65
JCU - January 2022 - 66
JCU - January 2022 - 67
JCU - January 2022 - 68
JCU - January 2022 - 69
JCU - January 2022 - 70
JCU - January 2022 - 71
JCU - January 2022 - 72
JCU - January 2022 - 73
JCU - January 2022 - 74
JCU - January 2022 - 75
JCU - January 2022 - 76
JCU - January 2022 - 77
JCU - January 2022 - 78
JCU - January 2022 - Cover3
JCU - January 2022 - Cover4
https://www.nxtbookmedia.com